Central Centrifugal Cicatricial Alopecia (CCCA)

Dr. Samantha A. Vergano, MD - Clinical Genetics, Genomics, Cytogenetics, Biochemical Genetics Specialist. Dr. Samantha A. Vergano, MD - Clinical Genetics, Genomics, Cytogenetics, Biochemical Genetics Specialist.
12 Views
Rx Dermatology, Skin Disease, and Allergy

Central centrifugal cicatricial alopecia (CCCA) is a scarring type of hair loss. “Scarring” means the hair follicle (the tiny pocket that grows hair) gets damaged and can be replaced by scar tissue, so that hair cannot grow back from that spot. It usually starts on the crown/vertex (top middle) of the scalp and slowly spreads outward in a circle. JAMA Network+3American Academy of Dermatology+3DermNet®+3

Central centrifugal cicatricial alopecia (CCCA) is a type of scarring hair loss that usually starts at the top middle (crown/vertex) of the scalp and slowly spreads outward. “Central” means the center of the scalp, “centrifugal” means it spreads out in a circle, and “cicatricial” means scar-forming. In CCCA, long-lasting scalp inflammation can damage the hair follicles so badly that the body replaces them with scar-like tissue, and then the hair may not grow back in those spots. American Academy of Dermatology+2NCBI+2

CCCA is seen most often in Black women, especially adults, but it can also happen in other groups and sometimes in men. Many people notice it slowly over months or years, which is why early diagnosis matters—treatment can help stop more permanent loss, even if it cannot “undo” scarred areas. Bad+3American Academy of Dermatology+3DermNet®+3

How CCCA damages hair

In CCCA, the body’s inflammation (swelling and “irritation” inside the skin) mainly targets hair follicles on the scalp. Over time, repeated inflammation can destroy important parts of the follicle, and the body heals by laying down fibrous scar tissue. When follicle openings disappear, the scalp can look smoother and shinier in that area. PMC+3NCBI+3DermNet®+3

CCCA can be tricky because early on you may still see hair, but the follicles are already under stress. That is why dermatologists often use tools like trichoscopy (scalp dermoscopy) and sometimes a scalp biopsy to confirm scarring and inflammation before the damage becomes permanent. NCBI+3PMC+3PubMed+3

Other names for CCCA

Hot comb alopecia: This older name was used because early reports linked the condition to hot-comb hair styling, but we now know CCCA can happen even without hot-comb use. Bad+2JAAD+2

Follicular degeneration syndrome: This is another older name used in medical history for the same disease group, focusing on follicle damage and scarring. Bad+1

Chemically induced cosmetic alopecia (older term): This name was used when people believed chemicals were the main cause, but today CCCA is considered multifactorial (more than one factor). Bad+2DermNet®+2

Types of CCCA

Here are common clinical patterns doctors may describe (real people can have overlap). PubMed+3JAMA Network+3DermNet®+3

  • Classic central/vertex pattern

  • Centrifugal “spreading circle” pattern

  • Diffuse crown thinning pattern

  • Patchy pattern beyond the crown

  • “Hidden/early” CCCA (biopsy changes with little visible loss)

  • Advanced end-stage scarring pattern JAMA Network+3PubMed+3PMC+3

1. Classic central/vertex pattern: Hair loss begins at the crown (vertex) and is most noticeable there first. This is the “typical” pattern the name CCCA describes. JAMA Network+2DermNet®+2

2. Centrifugal spreading pattern: The thin area gradually grows outward from the center, like a widening circle. This slow outward spread is a key clue for CCCA. NCBI+2DermNet®+2

3. Diffuse crown thinning pattern: Instead of a sharp bald patch, some people mainly see overall thinning and breakage around the crown area. This can be confused with other hair loss types unless the scalp is examined closely. JAMA Network+2PMC+2

4. Patchy pattern beyond the crown: Some patients show patchy loss outside the vertex area. This is one reason doctors warn that CCCA does not always look “perfectly central.” PubMed+1

5. Hidden/early CCCA: Research has reported biopsy findings consistent with CCCA even when obvious hair loss is not yet visible, meaning early disease can be present before the “bald spot” looks clear. PMC+1

6. Advanced end-stage scarring pattern: In later stages, the follicle openings may be gone in the affected area, meaning regrowth is unlikely there. Treatment focus becomes preventing spread and protecting remaining follicles. American Academy of Dermatology+2DermNet®+2

Causes and risk factors

CCCA does not have one single proven cause. Most experts describe it as a mix of genetics, inflammation, and (in some people) hair and scalp stressors. PMC+3DermNet®+3NCBI+3

1. Genetic tendency (family history): CCCA can run in families, suggesting inherited risk in some people. Genetics may make follicles more sensitive to inflammation or injury. NCBI+2DermNet®+2

2. PADI3 gene variants (in some families): Studies found variants in PADI3, a gene important for normal hair-shaft formation, in some people with CCCA. This does not explain all cases, but it supports a genetic role. PubMed+2DermNet®+2

3. Chronic follicle inflammation: Many descriptions of CCCA emphasize inflammatory changes around follicles. Repeated inflammation can lead to scarring over time. NCBI+2JAMA Network+2

4. “Fibrosis-prone” biology (scar-forming tendency): Some resources note CCCA can be seen with a higher tendency toward forming extra scar tissue, which may push the scalp toward fibrosis after inflammation. BAD Patient Hub+1

5. Tight traction hairstyles: Styles that pull tightly on the scalp (strong traction) have been linked in studies as a possible contributor in some people, likely by repeated stress on follicles. JAMA Network+2PMC+2

6. Tight braids and cornrows (when very tight or long-term): These can create ongoing traction and scalp stress, especially if they cause pain, bumps, or broken hairs at the crown. JAMA Network+2DermNet®+2

7. Weaves and extensions (especially if tight/heavy): Added hair can increase pulling and weight on follicles. This may worsen inflammation in a scalp already at risk. DermNet®+2PMC+2

8. Chemical relaxers (possible risk in some studies): Research has not been perfectly consistent, but some studies report an association between relaxer use and CCCA risk in some groups. PMC+2DermNet®+2

9. Heat styling and hot combing: Historically, CCCA was linked to hot comb use; today it is seen as a possible stressor rather than a single cause, because CCCA can occur without it. Bad+2JAAD+2

10. Frequent high-heat blow drying/flat ironing: Repeated high heat can damage hair shafts and irritate the scalp, which may add stress to vulnerable follicles (even if it is not the only trigger). DermNet®+1

11. Scalp infections or folliculitis (inflammation from germs): A major survey-based study suggested that inflammation, including possible bacterial infection, may contribute in some cases. JAMA Network+1

12. Long-term scalp irritation from harsh practices: Repeated rubbing, scratching, harsh brushing, or irritating products can keep the scalp inflamed, which may worsen scarring alopecia processes. NCBI+1

13. Mechanical breakage and repeated trauma at the crown: Constant stress at the crown (where CCCA often starts) may create a “weak zone” where inflammation and scarring become more likely. JAMA Network+2DermNet®+2

14. Autoimmune-style inflammation (immune mis-targeting): Patient information sources describe autoimmune-type factors as a possible mechanism—meaning the immune system may react in a harmful way around follicles. BAD Patient Hub+1

15. Being female (risk factor, not a fault): CCCA is reported far more often in women than men, which may relate to biology and also hair practices—but it can occur in anyone. JAMA Network+2DermNet®+2

16. African ancestry and tightly curled hair types (risk association): CCCA is most common in Black women, suggesting genetic and hair/follicle structure factors may play roles. This is a risk association, not something “wrong” with the hair. JAMA Network+2DermNet®+2

17. Age (often adult onset): Many references describe CCCA most commonly in adults (often middle age), though studies also report it can appear in adolescents. JAMA Network+2MDPI+2

18. Association with uterine fibroids (leiomyomas): Studies in Black women found an association between CCCA and uterine fibroids. This does not prove one causes the other, but may point to shared “fibrosis” pathways. PMC+2BAD Patient Hub+2

19. Possible metabolic links (mixed evidence): Older research suggested links with type 2 diabetes/metabolic issues, but newer work has found weaker or no links for many metabolic conditions. So doctors treat this as “possible but not settled.” JAMA Network+1

20. A combination effect (multi-factor trigger): Many expert summaries conclude CCCA likely happens when a person has a genetic tendency and then experiences repeated scalp stress and inflammation over time. DermNet®+2NCBI+2

Common symptoms and signs

Some people have no strong symptoms at first, so signs on the scalp may be the first clue. Bad.org.uk+2DermNet®+2

1. Slow thinning at the crown: The most common first sign is less hair density on the crown/vertex. It often spreads gradually. JAMA Network+2DermNet®+2

2. Hair breakage (short broken hairs): Many people notice the hair seems to break easily near the crown, even before obvious bald patches form. DermNet®+1

3. Widening part line near the top: The part may look wider because there are fewer healthy hairs growing in that central area. JAMA Network+1

4. Itching (pruritus): Some patients feel itch on the scalp due to inflammation around follicles. Bad.org.uk+2DermNet®+2

5. Burning feeling: A burning sensation can happen when the scalp is inflamed. Not everyone feels it, but it is a known symptom. Bad.org.uk+1

6. Tingling: Tingling can occur as part of scalp sensitivity from inflammation. If tingling is severe or spreads widely, doctors may also check other causes. Bad.org.uk+1

7. Tenderness or soreness: The scalp may hurt when touched, combed, or styled, especially during active inflammation. Bad.org.uk+1

8. Scalp sensitivity to hairstyles: Styles that were once comfortable may start to feel painful, tight, or “too much” around the crown. This can be a warning sign to reduce traction. DermNet®+2JAMA Network+2

9. Redness around follicles: Some people have visible redness (erythema), often around follicle openings, showing active irritation. NCBI+2DermNet®+2

10. Scale around follicles: Fine scale around hairs can be seen in scarring alopecias, including CCCA, and may be picked up better with dermoscopy/trichoscopy. DermNet®+2PMC+2

11. Small bumps (perifollicular papules): Inflammation can produce small bumps around follicles. People may describe a “bumpy scalp” at the crown. DermNet®+1

12. Pustules (pimple-like bumps) in some cases: Some descriptions include follicular pustules, which can suggest stronger inflammation or infection on top of CCCA activity. DermNet®+1

13. Smooth shiny scalp in advanced areas: When follicles are destroyed and replaced by scar tissue, the scalp can look smooth with fewer visible follicle openings. DermNet®+2NCBI+2

14. Loss of follicle openings (“no pores” where hair should be): Clinicians look for loss of follicular openings as a key clue for scarring alopecia rather than simple shedding. NCBI+2DermNet®+2

15. Patchy loss outside the crown (in some people): Although “classic” CCCA is central, published cases show some people have patchy loss beyond the vertex, so pattern alone is not the whole story. PubMed+1

Diagnostic tests for CCCA

Doctors often diagnose CCCA using history + scalp exam, then confirm (when needed) with trichoscopy and biopsy, while also ruling out other causes of hair loss. PMC+3NCBI+3JAMA Network+3

Physical exam tests

1. Scalp pattern inspection: The clinician checks where thinning starts (often crown), how it spreads, and whether it matches a typical CCCA pattern or an atypical one. JAMA Network+2PubMed+2

2. Follicular opening check: The doctor looks closely for missing follicle openings in thin areas. Missing openings strongly suggests a scarring process, not just temporary shedding. NCBI+2JAAD+2

3. Inflammation check (redness/scale/pustules): The scalp is examined for redness, scale, bumps, or pustules that signal active inflammation needing treatment. NCBI+2DermNet®+2

4. Hair density and part-width measurement: Clinicians may measure density and compare areas over time, because CCCA can progress slowly and changes can be subtle. JAMA Network+1

5. Standardized scalp photographs: Photos taken the same way each visit help track progression and response to treatment, especially when changes are gradual. NCBI+1

Manual tests

6. Hair pull test: The clinician gently pulls a small group of hairs to see if many shed easily. This is mainly to check for extra shedding (like telogen effluvium) happening along with CCCA. Europe PMC+1

7. Hair tug test (breakage test): The clinician tugs the hair shaft to see if it snaps, which helps separate hair breakage from true shedding and guides hair-care advice. DermNet®+1

8. Gentle scalp palpation: Touching the scalp checks for tenderness, warmth, or thickened areas that can indicate active inflammation or scarring. Bad.org.uk+1

9. Hairstyle/traction assessment: The clinician checks for signs of traction stress (tension areas, breakage, pain with styles) because traction can worsen inflammation in susceptible scalps. JAMA Network+2PMC+2

Lab and pathological tests

10. Scalp biopsy (punch biopsy): This is one of the most important confirmation tests. A small piece of scalp is examined under a microscope to show scarring, inflammation type, and follicle damage. NCBI+2JAMA Network+2

11. Biopsy site selection using dermoscopy clues: Dermoscopy findings (like the peripilar white/gray halo) can help choose the best biopsy spot, increasing the chance of a clear diagnosis. PubMed+1

12. Histopathology with standard stains (H&E): Pathology uses routine staining to look for scarring (fibrosis), loss of sebaceous glands, and inflammatory patterns typical of scarring alopecia. NCBI+2PMC+2

13. PAS stain or fungal evaluation (when needed): If scale, broken hairs, or patches suggest fungus, labs may use special stains or tests to rule out tinea capitis and similar infections. NCBI+1

14. Bacterial culture (when pustules/crust suggest infection): If pustules or oozing are present, culture can identify bacteria and guide treatment, because infection-related inflammation can worsen disease activity. JAMA Network+1

15. Blood tests to rule out common contributors (case-by-case): Some clinicians check tests like iron/ferritin or thyroid function when the story suggests other hair-loss causes are present too, because more than one problem can overlap. NCBI+1

Electrodiagnostic / computer-based objective tests

16. Trichogram: A trichogram examines plucked hairs under a microscope to estimate hair-cycle patterns and shaft changes. It does not “prove” CCCA alone, but it can support evaluation when shedding/breakage questions exist. Actas Dermo-Sifiliográficas+1

17. Phototrichogram (computer-assisted hair counts): This uses close-up photos over time to count hairs and measure growth changes. It is often used for monitoring and for objective tracking in hair disorders. IJDVL+1

18. TrichoScan (computer-based phototrichogram tool): TrichoScan is a software-assisted method used to measure hair growth parameters more objectively than “just looking,” mainly for tracking over time. PMC+1

Imaging tests

19. Trichoscopy (scalp dermoscopy): This is a key noninvasive imaging method. In CCCA, a well-known clue is the peripilar white/gray halo, plus other scarring patterns, which helps diagnosis and biopsy targeting. PubMed+2PMC+2

20. High-frequency scalp ultrasound / advanced imaging (specialist use): High-frequency ultrasound and other newer imaging methods can help evaluate scarring alopecias and activity in some settings, but they are usually add-ons, not replacements for exam/biopsy. PMC+2PubMed+2

Goals of treatment

The main goal is to stop the inflammation early so you keep as many working hair follicles as possible. A second goal is to reduce symptoms like burning, tenderness, itching, or scalp “soreness.” A third goal is to support thicker growth from follicles that are still alive (this is where growth helpers like minoxidil may help, but they cannot “unscar” a scarred follicle). Early diagnosis and gentle hair care choices matter a lot because CCCA can keep progressing if the triggers and inflammation continue. American Academy of Dermatology+2NCBI+2

Non-pharmacological treatments (therapies and others)

  1. Stop tight hairstyles (traction reduction). Purpose: reduce pulling stress on follicles. Mechanism: less mechanical injury means less inflammation and less ongoing follicle damage. Practical idea: avoid tight braids, tight ponytails, tight buns, and heavy extensions. American Academy of Dermatology+1

  2. Avoid frequent relaxers/harsh chemicals. Purpose: reduce scalp irritation. Mechanism: chemical irritation can worsen inflammation and break fragile hairs, which can add to shedding and discomfort. If used, spacing and professional technique matters. American Academy of Dermatology+1

  3. Reduce heat (hot comb/flat iron/blow-dry heat). Purpose: lower thermal injury. Mechanism: heat can inflame scalp skin and weaken hair shafts, making breakage look like “more hair loss.” Use lower heat and fewer passes. American Academy of Dermatology+1

  4. Gentle cleansing routine. Purpose: keep scalp clean without irritation. Mechanism: gentle washing removes sweat/oil/product buildup that can aggravate itching and inflammation while protecting the skin barrier. American Academy of Dermatology+1

  5. Treat dandruff/seborrheic dermatitis if present. Purpose: reduce extra scalp inflammation. Mechanism: controlling yeast-related dandruff can reduce itching and scratching, which can worsen CCCA discomfort. NCBI+1

  6. Limit heavy scalp occlusion (thick oils/pomades on scalp). Purpose: reduce follicle blockage and irritation. Mechanism: heavy buildup may increase itching and scratching in some people; keeping the scalp comfortable helps reduce trauma. NCBI+1

  7. “Low manipulation” styling. Purpose: reduce daily friction and breakage. Mechanism: less brushing/comb stress means less hair-shaft breakage that can hide true improvement. American Academy of Dermatology+1

  8. Satin/silk scarf or pillowcase. Purpose: reduce friction at night. Mechanism: less rubbing means less breakage and less scalp irritation. NCBI+1

  9. Avoid scratching (itch control habits). Purpose: protect follicles from trauma. Mechanism: scratching creates micro-injury that keeps inflammation active; using cool compresses or gentle tapping can help. NCBI+1

  10. Regular photo tracking (same light, same angle). Purpose: measure progress realistically. Mechanism: CCCA changes slowly; photos help you and your dermatologist see if spread is stopping. JAAD+1

  11. Trichoscopy/dermoscopy follow-up (clinic tool). Purpose: monitor inflammation signs. Mechanism: scalp magnification can show scale, redness, and follicle openings to judge activity over time. JAAD+1

  12. Scalp biopsy when diagnosis is uncertain. Purpose: confirm CCCA vs other scarring alopecias. Mechanism: under the microscope, doctors can see scarring patterns and inflammation type, which guides treatment choices. NCBI+1

  13. Stress management and sleep support. Purpose: support overall inflammatory balance and coping. Mechanism: stress can worsen itching behaviors and adherence; calmer routines help long-term care plans. NCBI+1

  14. Cosmetic camouflage (fibers, scalp concealers). Purpose: improve appearance confidence. Mechanism: does not treat disease, but reduces distress while medical therapy works slowly. Bad+1

  15. Wigs/protective pieces that do not pull. Purpose: reduce manipulation while protecting appearance. Mechanism: low-tension options avoid traction and allow scalp access for medicines. Bad+1

  16. Low-level laser therapy (LLLT) as an add-on (selected cases). Purpose: support thicker growth from surviving follicles. Mechanism: light may change cellular signaling and blood flow; evidence for scarring alopecia is limited, so it’s optional. Jidsp Online+1

  17. Microneedling (specialist-guided add-on). Purpose: help topical absorption and growth signaling. Mechanism: tiny controlled micro-injury can trigger healing signals; in scarring alopecia, evidence is still limited, so avoid DIY. Jidsp Online+1

  18. PRP (platelet-rich plasma) injections (clinic procedure). Purpose: try to support regrowth where follicles remain. Mechanism: concentrated platelets release growth factors; evidence in CCCA is emerging and not guaranteed. Jidsp Online+1

  19. Weight-neutral, balanced nutrition and hydration. Purpose: reduce avoidable shedding from deficiency. Mechanism: hair follicles need protein, iron, zinc, and vitamin D support; correcting deficiencies helps the “background” hair health. Office of Dietary Supplements+2Office of Dietary Supplements+2

  20. Patient education + consistent routine. Purpose: improve long-term results. Mechanism: CCCA often needs months of steady care; understanding “stop inflammation first, then regrow what’s possible” prevents early stopping. JAAD+1

Drug treatments

  1. Clobetasol propionate 0.05% (solution/foam/spray) — Class: super-potent topical corticosteroid. Typical label use: thin layer to affected scalp short-term. Time: often used in “bursts,” then tapered. Purpose: calm inflammation quickly. Mechanism: reduces inflammatory signaling in skin. Side effects: burning, thinning skin, acne-like bumps, and systemic absorption if overused. accessdata.fda.gov+2accessdata.fda.gov+2

  2. Fluocinonide 0.05% solution — Class: high-potency topical corticosteroid. Time: used for active inflammation, then reduced frequency. Purpose: reduce redness, itching, tenderness. Mechanism: anti-inflammatory steroid action in the scalp skin. Side effects: irritation, skin thinning with long use. Office of Dietary Supplements+1

  3. Betamethasone dipropionate (lotion/solution) — Class: potent topical corticosteroid. Purpose: calm scalp inflammation and symptoms. Mechanism: decreases immune activity in the skin. Time: short courses with breaks. Side effects: burning, folliculitis, skin thinning if overused. Office of Dietary Supplements+1

  4. Fluocinolone acetonide scalp oil — Class: topical corticosteroid for scalp inflammation. Purpose: reduce itch and scale while being easier to apply on hair-bearing scalp. Mechanism: steroid anti-inflammatory effect. Side effects: irritation, acne-like bumps, skin thinning with long use. Office of Dietary Supplements+1

  5. Triamcinolone acetonide intralesional injections (e.g., Kenalog-10) — Class: corticosteroid injection. Time: often repeated every few weeks by a dermatologist when CCCA is active. Purpose: deliver anti-inflammatory medicine deeper around follicles. Mechanism: locally suppresses inflammatory cells. Side effects: scalp denting/skin thinning at injection spots if dosing is too strong. accessdata.fda.gov+1

  6. Doxycycline — Class: tetracycline antibiotic (also anti-inflammatory). Time: often weeks to months for inflammatory scalp disease (doctor-guided). Purpose: reduce inflammatory signals and tenderness. Mechanism: decreases certain inflammatory enzymes and cytokines. Side effects: stomach upset, sun sensitivity, yeast overgrowth. accessdata.fda.gov+2JAAD+2

  7. Minocycline — Class: tetracycline antibiotic (anti-inflammatory). Purpose: alternative when doxycycline is not tolerated. Mechanism: anti-inflammatory actions plus antibacterial coverage if folliculitis coexists. Time: doctor-guided. Side effects: dizziness, skin discoloration (rare), stomach upset. accessdata.fda.gov+1

  8. Hydroxychloroquine (Plaquenil) — Class: antimalarial / immunomodulator. Time: usually months before full effect, with monitoring. Purpose: calm immune-driven inflammation in scarring alopecias. Mechanism: changes antigen processing and immune signaling. Side effects: stomach upset; important rare risk includes eye toxicity, so eye checks are used. accessdata.fda.gov+2JAAD+2

  9. Tacrolimus ointment (Protopic) — Class: topical calcineurin inhibitor. Purpose: steroid-sparing anti-inflammatory option for sensitive areas or long-term use plans. Mechanism: reduces T-cell activation in skin. Time: applied in courses as directed. Side effects: burning/stinging at first. accessdata.fda.gov+2accessdata.fda.gov+2

  10. Pimecrolimus cream (Elidel) — Class: topical calcineurin inhibitor. Purpose: reduce inflammation when steroids are not ideal. Mechanism: decreases inflammatory T-cell signaling in skin. Time: dermatologist-guided. Side effects: burning, irritation; not for infected skin. accessdata.fda.gov+1

  11. Ketoconazole 2% shampoo (Nizoral) — Class: antifungal shampoo. Purpose: treat dandruff/seborrheic dermatitis that can worsen itch and inflammation. Mechanism: reduces Malassezia yeast and scalp inflammation. Time: used a few times weekly per clinician advice. Side effects: dryness/irritation. accessdata.fda.gov+1

  12. Clindamycin topical (solution/lotion) — Class: topical antibiotic. Purpose: help if pustules/folliculitis overlap with CCCA. Mechanism: lowers bacterial load and local inflammation. Time: applied to affected areas as directed. Side effects: dryness, irritation; rarely diarrhea with heavy use. Office of Dietary Supplements+1

  13. Oral prednisone (short course, specialist-only) — Class: systemic corticosteroid. Purpose: rapid control of severe flare symptoms (tenderness/burning) when needed. Mechanism: broad immune suppression. Time: short course then taper (doctor-guided). Side effects: blood sugar changes, mood changes, sleep issues, infection risk. accessdata.fda.gov+1

  14. Mycophenolate mofetil (CellCept) — Class: immunosuppressant (IMPDH inhibitor). Purpose: resistant inflammatory scarring alopecia under specialist care. Mechanism: reduces lymphocyte proliferation. Time: months with lab monitoring. Side effects: infection risk, stomach upset, low blood counts; pregnancy warnings. accessdata.fda.gov+1

  15. Cyclosporine (Neoral) — Class: systemic immunosuppressant. Purpose: severe inflammatory activity not controlled by safer options. Mechanism: blocks calcineurin signaling to reduce T-cell activity. Time: usually limited duration with close monitoring. Side effects: high blood pressure, kidney effects, infection risk. accessdata.fda.gov+1

  16. Methotrexate — Class: antimetabolite / immunomodulator. Purpose: reduce chronic inflammation in scarring alopecia (selected cases). Mechanism: affects folate pathways and immune signaling. Time: weekly dosing under specialist care with labs. Side effects: nausea, mouth sores, liver risks; strict monitoring. accessdata.fda.gov+1

  17. Spironolactone (Aldactone) — Class: anti-androgen / diuretic. Purpose: helpful mainly when female pattern hair loss is also present, to reduce androgen effect on follicles (not a direct CCCA “cure”). Mechanism: blocks androgen receptor and reduces androgen signaling. Time: months. Side effects: breast tenderness, menstrual changes, high potassium (needs monitoring). accessdata.fda.gov+2American Academy of Dermatology+2

  18. Finasteride (Propecia) — Class: 5-alpha-reductase inhibitor. Purpose: for androgenetic hair loss (men only on label) and sometimes considered off-label in selected cases; may be used if pattern hair loss overlaps. Mechanism: lowers DHT. Time: 6–12 months to judge. Side effects: sexual side effects; pregnancy risk for exposed fetus. accessdata.fda.gov+1

  19. Dutasteride (Avodart) — Class: 5-alpha-reductase inhibitor. Purpose: similar “overlap pattern hair loss” role (not a direct CCCA anti-scar treatment). Mechanism: reduces DHT more strongly than finasteride. Time: months. Side effects: sexual side effects; pregnancy warnings. accessdata.fda.gov+1

  20. Oral minoxidil (Loniten) (specialist-only, off-label for hair) — Class: vasodilator (label: hypertension). Purpose in hair care: support thicker growth from remaining follicles, often as an add-on. Mechanism: shifts follicles into growth phase and may increase follicle size. Side effects: low blood pressure, swelling, fast heartbeat, unwanted hair growth. accessdata.fda.gov+1

Dietary molecular supplements

  1. Vitamin D (if low). Dosage: depends on blood level; many people use clinician-guided daily dosing. Function: supports bone, immune balance, and general health. Mechanism: acts like a hormone affecting many genes and immune pathways. Too much can be harmful, so testing helps. Office of Dietary Supplements+1

  2. Iron (only if iron stores are low). Dosage: depends on ferritin/iron studies. Function: supports oxygen delivery and normal hair cycling. Mechanism: iron is needed for hemoglobin and many enzymes; low iron can increase shedding. Side effects: constipation, stomach upset if overdosed. Office of Dietary Supplements+1

  3. Zinc. Dosage: stay near recommended intakes unless a clinician advises more. Function: supports skin barrier and immune function. Mechanism: zinc is a cofactor for many enzymes and healing processes. Too much zinc can cause problems and affect copper balance. Office of Dietary Supplements+1

  4. Omega-3 fatty acids (EPA/DHA). Dosage: varies by product; food sources (fatty fish) are preferred. Function: supports general anti-inflammatory balance. Mechanism: omega-3s can shift the body toward less inflammatory lipid mediators. It is supportive, not a cure for scarring alopecia. Office of Dietary Supplements+1

  5. Protein (as a “supplement” only if diet is low). Dosage: aim for adequate daily protein from food; shakes can help if you cannot meet needs. Function: hair shaft is mostly protein. Mechanism: adequate amino acids support keratin production and reduce breakage-type shedding. NCBI+1

  6. Biotin (only if deficiency risk). Dosage: avoid mega-doses unless prescribed. Function: supports keratin infrastructure in deficiency states. Mechanism: biotin is a cofactor in metabolism; true deficiency is uncommon, so routine high dosing is often unnecessary. Office of Dietary Supplements+1

  7. Vitamin B12 (if low). Dosage: depends on lab results and cause. Function: supports red blood cell formation and nerve health, indirectly supporting hair growth environment. Mechanism: B12 is needed for DNA synthesis; deficiency can increase shedding. Office of Dietary Supplements+1

  8. Folate (if low). Dosage: clinician-guided, especially if you also use medicines that affect folate (like methotrexate plans). Function: supports cell turnover. Mechanism: folate supports DNA synthesis in fast-dividing cells, including hair matrix cells. Office of Dietary Supplements+1

  9. Vitamin C (food first). Dosage: usually through fruits/vegetables. Function: supports collagen and helps iron absorption. Mechanism: vitamin C supports connective tissue and improves non-heme iron absorption, which may help if iron intake is borderline. Office of Dietary Supplements+1

  10. Probiotics (optional, supportive). Dosage: product-dependent. Function: may support gut comfort during long antibiotic courses and general immune balance. Mechanism: certain strains can influence gut barrier and immune signaling; effects vary by product and person. Office of Dietary Supplements+1

Immunity / regenerative / stem-cell” drug options

  1. Topical metformin (compounded; experimental). Dosage: compounded (no standard FDA dose). Function: being studied for anti-fibrotic/regenerative support in scarring alopecia. Mechanism: may affect fibrosis pathways and inflammation. Evidence is early (case reports/series), so this is specialist-only. jaadcasereports.org+1

  2. Tofacitinib (Xeljanz) (systemic JAK inhibitor; very high-risk). Dosage: per FDA label for approved diseases (not CCCA). Function: immune pathway control in some inflammatory hair diseases; CCCA evidence is limited. Mechanism: blocks JAK signaling to reduce inflammatory cytokines. Serious side effects exist; specialist monitoring is required. accessdata.fda.gov+1

  3. Ruxolitinib cream (Opzelura) (topical JAK inhibitor; not CCCA-approved). Dosage: per label for approved skin conditions. Function: local immune calming in skin; scarring alopecia evidence is uncertain. Mechanism: JAK inhibition can reduce inflammatory signaling in skin. Use requires dermatologist judgment. accessdata.fda.gov+1

  4. Baricitinib (Olumiant) (systemic JAK inhibitor). Dosage: per label for approved indications (not CCCA). Function: immune modulation; used in some hair disorders but not proven for CCCA. Mechanism: reduces inflammatory cytokine signaling. Side effects can be serious, so it is specialist-only. accessdata.fda.gov+1

  5. Pioglitazone (Actos) (PPAR-γ agonist; off-label concept). Dosage: per diabetes label; not a CCCA-approved drug. Function: studied mainly in other scarring alopecias as an anti-inflammatory/anti-fibrotic idea. Mechanism: PPAR-γ signaling may matter in scarring alopecia biology; evidence for CCCA is not strong. accessdata.fda.gov+1

  6. Low-dose naltrexone (LDN) (off-label; evidence mainly in other scarring alopecias). Dosage: much lower than standard label doses (so it must be prescriber-directed). Function: may reduce itch/pain and inflammation in some scarring alopecias. Mechanism: immune-modulating effects are proposed; evidence is limited and not CCCA-specific. JAAD+1

Procedures and surgeries (procedures + why they’re done)

  1. Scalp biopsy (procedure). Why: confirm CCCA and rule out other scarring alopecias. It guides the safest long-term plan because treatments differ across scarring types. NCBI+1

  2. Intralesional steroid injections (procedure). Why: deliver strong anti-inflammatory medicine directly around follicles when the disease is active. It can reduce tenderness and slow spread in many patients. JAAD+1

  3. Hair transplantation (surgery; only when disease is “quiet”). Why: restore hair in stable scarred areas after inflammation is controlled for a long time. If done during active disease, new grafts can also fail. Bad+1

  4. Scar revision/excision (selected cases). Why: remove very small, stable scar patches or adjust hairline/scar shape in carefully chosen patients; it does not treat the underlying inflammatory tendency. NCBI+1

  5. Camouflage procedures (e.g., scalp micropigmentation). Why: improve appearance by reducing scalp “show” through color illusion; it does not stop CCCA, so it is best after medical control. Bad+1

Preventions (to reduce risk of progression and flare)

  1. Start treatment early when you notice crown thinning, burning, or tenderness. American Academy of Dermatology+1

  2. Avoid tight hairstyles and long-term traction. American Academy of Dermatology+1

  3. Reduce heat and chemical stress on the scalp. American Academy of Dermatology+1

  4. Keep dandruff controlled to reduce itch and scratching. accessdata.fda.gov+1

  5. Use medicines exactly as directed (do not overuse strong steroids). accessdata.fda.gov+1

  6. Avoid picking/scratching—treat itch early. NCBI+1

  7. Do regular follow-ups so your plan can be adjusted before spread happens. JAAD+1

  8. Correct iron/vitamin D/zinc problems if tests show low levels. Office of Dietary Supplements+2Office of Dietary Supplements+2

  9. Choose “low manipulation” hair routines to reduce breakage confusion. NCBI+1

  10. Ask your stylist to prioritize scalp comfort and low tension (a “CCCA-safe” plan). Bad+1

When to see doctors

See a dermatologist (or a hair-loss specialist dermatologist) if you notice thinning at the crown, widening part, scalp burning/tenderness/itch, scalp scaling, or shiny areas with fewer follicle openings. Also go soon if hair loss is spreading month to month, or if home hair-care changes are not helping. Early medical control is the best way to prevent permanent loss from scarring. American Academy of Dermatology+2NCBI+2

What to eat and what to avoid

  1. Eat: enough protein (eggs, fish, lentils) to support hair shaft building. Avoid: very low-protein dieting. NCBI+1

  2. Eat: iron-rich foods if you are prone to low iron (meat, legumes, leafy greens). Avoid: taking iron pills without testing. Office of Dietary Supplements+1

  3. Eat: vitamin D sources (safe sunlight + foods/supplement if needed). Avoid: high-dose vitamin D without guidance. Office of Dietary Supplements+1

  4. Eat: zinc sources (seafood, beans, nuts). Avoid: long-term high-dose zinc unless prescribed. Office of Dietary Supplements+1

  5. Eat: omega-3 sources (fatty fish, flax/chia). Avoid: ultra-processed fats as your main fat source. Office of Dietary Supplements+1

  6. Eat: colorful fruits/vegetables for antioxidants. Avoid: very high sugar patterns that worsen overall inflammation. Office of Dietary Supplements+1

  7. Eat: enough water and fiber for gut comfort (especially if on antibiotics). Avoid: dehydration. accessdata.fda.gov+1

  8. Eat: foods that support a calm scalp routine (balanced meals). Avoid: “miracle” hair diets claiming to reverse scarring. JAAD+1

  9. Eat: if you take supplements, choose tested brands and simple formulas. Avoid: stacking many supplements at once. Office of Dietary Supplements+1

  10. Eat: adequate calories for growth. Avoid: crash dieting, which can trigger shedding (telogen effluvium) on top of CCCA. NCBI+1

FAQs

  1. Is CCCA permanent? The scarring part can be permanent because scar tissue replaces damaged follicles, but early treatment can stop spread and protect remaining follicles. American Academy of Dermatology+1

  2. Can hair grow back in CCCA? Sometimes hair thickens where follicles are still alive, but fully scarred areas often do not regrow hair, which is why early care matters. American Academy of Dermatology+1

  3. Does CCCA only affect Black women? It is most common in women of African descent, but it can occur in others too; hair practices and biology both matter. NCBI+1

  4. What is the first-line treatment? Many plans start with strong topical anti-inflammatory treatment (often a potent steroid) plus hair-care changes, and then adjust based on response. JAAD+1

  5. Do oils cause CCCA? Oils do not “cause” CCCA by themselves, but heavy buildup can worsen itch in some people; the bigger issue is inflammation and damaging styling practices. NCBI+1

  6. Is dandruff related to CCCA? Dandruff does not equal CCCA, but uncontrolled dandruff can increase itch and scratching, which can worsen scalp inflammation and discomfort. accessdata.fda.gov+1

  7. Can minoxidil cure CCCA? No. Minoxidil can support growth from surviving follicles, but it does not remove scar tissue; anti-inflammatory treatment is still key. JAAD+1

  8. How long does treatment take? CCCA often needs months to judge control; scarring alopecia care is usually long-term and adjusted over time. JAAD+1

  9. Will stopping braids help? Reducing tight styles can lower traction and irritation, which supports a calmer scalp and may help slow worsening in people where tension contributes. American Academy of Dermatology+1

  10. Are steroid scalp medicines safe? They can be safe when used correctly, but overuse can thin the skin and cause other side effects, so follow the dermatologist’s plan closely. accessdata.fda.gov+1

  11. Why might I need a biopsy? A biopsy can confirm CCCA and rule out other scarring alopecias that look similar but need different treatment choices. NCBI+1

  12. Can children/teens get CCCA? It is less common, but scalp scarring alopecia can occur at younger ages; a dermatologist should evaluate any progressive crown loss. NCBI+1

  13. Is hair transplant a good idea? It can help only when the disease has been inactive for a long time; transplanting into active CCCA can fail because inflammation can damage grafts. JAAD+1

  14. Do supplements fix CCCA? Supplements help only if you have a deficiency or poor intake; they do not “reverse scarring,” but they can support healthier growth from remaining follicles. Office of Dietary Supplements+1

  15. What is the biggest “mistake” to avoid? Waiting too long while using high-tension styling or harsh scalp practices—because ongoing inflammation can quietly scar follicles over time. American Academy of Dermatology+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 16, 2025.

PDF Documents For This Disease Condition

  1. Rare Diseases and Medical Genetics.[rxharun.com]
  2. i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com]
  3. the-UK-rare-diseases-framework.[rxharun.com]
  4. National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com]
  5. History of rare diseases and their genetic.[rxharun.com]
  6. health-care-and-rare-disorders.[rxharun.com]
  7. Rare Disease Registries.[rxharun.com]
  8. autoimmune-Rare-Genetic-Diseases.[rxharun.com]
  9. Rare Genetic Diseases.[rxharun.com]
  10. rare-disease-day.[rxharun.com]
  11. Rare_Disease_Drugs_e.[rxharun.com]
  12. fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com]
  13. rare-and-inherited-disease-eligibility-criteria.[rxharun.com]
  14. FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]
  15. FDA-rare-disease-lists.[rxharun.com]
  16. 30212783fnl_Rare Disease.[rxharun.com]
  17. FDA-rare-disease-list.[rxharun.com]
  18. List of rare disease.[rxharun.com]
  19. Genome Res.-2025-Steyaert-755-68.[rxharun.com]
  20. uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com]
  21. PIIS2949774424010355.[rxharun.com]
  22. hidden-costs-2016.[rxharun.com]
  23. B156_CONF2-en.[rxharun.com]
  24. IRDiRC_State-of-Play-2018_Final.[rxharun.com]
  25. IRDR_2022Vol11No3_pp96_160.[rxharun.com]
  26. from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com]
  27. Rare disease fda.[rxharun.com]
  28. England-Rare-Diseases-Action-Plan-2022.[rxharun.com]
  29. SCRDAC 2024 Report.[rxharun.com]
  30. CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com]
  31. Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com]
  32. rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com]
  33. ENG_White paper_A4_Digital_FINAL.[rxharun.com]
  34. UK_Strategy_for_Rare_Diseases.[rxharun.com]
  35. MalaysiaRareDiseaseList.[rxharun.com]
  36. EURORDISCARE_FULLBOOKr.[rxharun.com]
  37. EMHJ_1999_5_6_1104_1113.[rxharun.com]
  38. national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com]
  39. be-counted-052722-WEB.[rxharun.com]
  40. RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com]
  41. genomic-analysis-of-rare-disease-brochure.[rxharun.com]
  42. List-of-rare-diseases.[rxharun.com]
  43. RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com]
  44. rdnumbers.[rxharun.com] .
  45. Rare disease atoz .[rxharun.com]
  46. EmanPublisher_12_5830biosciences-.[rxharun.com]

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK208609/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/
  3. https://rarediseases.org/rare-diseases/
  4. https://rarediseases.info.nih.gov/diseases
  5. https://en.wikipedia.org/w/index.php?title=Category:Rare_diseases
  6. https://en.wikipedia.org/wiki/List_of_genetic_disorders
  7. https://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disorders
  8. https://medlineplus.gov/genetics/condition/
  9. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  10. https://www.fda.gov/patients/rare-diseases-fda
  11. https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-program
  12. https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134
  13. https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltext
  14. https://www.ncbi.nlm.nih.gov/mesh?
  15. https://www.rarediseasesinternational.org/working-with-the-who/
  16. https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7
  17. https://www.rarediseasesnetwork.org/
  18. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-disease
  19. https://www.raregenomics.org/rare-disease-list
  20. https://www.astrazeneca.com/our-therapy-areas/rare-disease.html
  21. https://bioresource.nihr.ac.uk/rare
  22. https://www.roche.com/solutions/focus-areas/neuroscience/rare-diseases
  23. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  24. https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomics
  25. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  26. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026
  27. https://wikicure.fandom.com/wiki/Rare_Diseases
  28. https://www.wikidoc.org/index.php/List_of_genetic_disorders
  29. https://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/
  30. https://www.orpha.net/en/disease/list
  31. https://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspx
  32. https://ojrd.biomedcentral.com/
  33. https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_en
  34. https://bioportal.bioontology.org/ontologies/ORDO
  35. https://www.orpha.net/en/disease/list
  36. https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions
  37. https://www.gao.gov/products/gao-25-106774
  38. https://www.gene.com/partners/what-we-are-looking-for/rare-diseases
  39. https://www.genome.gov/For-Patients-and-Families/Genetic-Disorders
  40. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  41. https://my.clevelandclinic.org/health/diseases/21751-genetic-disorders
  42. https://globalgenes.org/rare-disease-facts/
  43. https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nord
  44. https://byjus.com/biology/genetic-disorders/
  45. https://www.cdc.gov/genomics-and-health/about/genetic-disorders.html
  46. https://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/
  47. https://www.thegenehome.com/basics-of-genetics/disease-examples
  48. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  49. https://www.pfizerclinicaltrials.com/our-research/rare-diseases
  50. https://clinicaltrials.gov/ct2/results?recrs
  51. https://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdf
  52. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  53. https://www.nibib.nih.gov/
  54. https://www.nei.nih.gov/
  55. https://oxfordtreatment.com/
  56. https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/
  57. https://www.nccih.nih.gov/health
  58. https://catalog.ninds.nih.gov/
  59. https://www.aarda.org/diseaselist/
  60. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  61. https://www.nibib.nih.gov/
  62. https://www.nia.nih.gov/health/topics
  63. https://www.nichd.nih.gov/
  64. https://www.nimh.nih.gov/health/topics
  65. https://www.nichd.nih.gov/
  66. https://www.niehs.nih.gov/
  67. https://www.nimhd.nih.gov/
  68. https://www.nhlbi.nih.gov/health-topics
  69. https://obssr.od.nih.gov/.
  70. https://www.nichd.nih.gov/health/topics
  71. https://rarediseases.info.nih.gov/diseases
  72. https://beta.rarediseases.info.nih.gov/diseases
  73. https://orwh.od.nih.gov/

Related Articles
RxHarun
Logo
Register New Account